+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Recent advances in metabolomics in neurological disease, and future perspectives



Recent advances in metabolomics in neurological disease, and future perspectives



Analytical and Bioanalytical Chemistry 405(25): 8143-8150



Discovery of clinically relevant biomarkers for diseases has revealed metabolomics has potential advantages that classical diagnostic approaches do not. The great asset of metabolomics is that it enables assessment of global metabolic profiles of biofluids and discovery of biomarkers distinguishing disease status, with the possibility of enhancing clinical diagnostics. Most current clinical chemistry tests rely on old technology, and are neither sensitive nor specific for a particular disease. Clinical diagnosis of major neurological disorders, for example Alzheimer's disease and Parkinson's disease, on the basis of current clinical criteria is unsatisfactory. Emerging metabolomics is a powerful technique for discovering novel biomarkers and biochemical pathways to improve diagnosis, and for determination of prognosis and therapy. Identifying multiple novel biomarkers for neurological diseases has been greatly enhanced with recent advances in metabolomics that are more accurate than routine clinical practice. Cerebrospinal fluid (CSF), which is known to be a rich source of small-molecule biomarkers for neurological and neurodegenerative diseases, and is in close contact with diseased areas in neurological disorders, could potentially be used for disease diagnosis. Metabolomics will drive CSF analysis, facilitate and improve the development of disease treatment, and result in great benefits to public health in the long-term. This review covers different aspects of CSF metabolomics and discusses their significance in the postgenomic era, emphasizing the potential importance of endogenous small-molecule metabolites in this emerging field.

(PDF emailed within 0-6 h: $19.90)

Accession: 055398118

Download citation: RISBibTeXText

PMID: 23715678

DOI: 10.1007/s00216-013-7061-4


Related references

Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease. Molecular Neurodegeneration 14(1): 3-3, 2019

Alzheimer's disease: recent advances and future perspectives. Journal of Alzheimer's Disease 33 Suppl 1: S185-S194, 2013

Recent advances in the research of pathophysiology in inflammatory bowel disease and future perspectives. Nihon Shokakibyo Gakkai Zasshi 115(3): 244-253, 2018

Progressive renal diseases: recent advances in diagnosis and treatments. Topics: III. Recent topics; 1. Future perspectives of kidney disease. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(5): 1166-1171, 2013

Biodegradable stents for coronary artery disease treatment: Recent advances and future perspectives. Materials Science and Engineering. C, Materials for Biological Applications 91: 163-178, 2018

Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications. World Journal of Gastroenterology 22(1): 417-426, 2017

Recent advances in the application of metabolomics to Alzheimer's Disease. Biochimica et Biophysica Acta 1842(8): 1232-1239, 2014

Mechanisms and Therapeutic Strategies for Major Neurological Disorders: Current Advances and Future Perspectives. Current Medicinal Chemistry 2015, 2015

Thymosin alpha 1 and HIV-1: recent advances and future perspectives. Future Microbiology 12: 141-155, 2017

Sortase A Inhibitors: Recent Advances and Future Perspectives. Journal of Medicinal Chemistry 58(23): 9108-9123, 2016

Plant volatiles: recent advances and future perspectives. Critical Reviews in Plant Sciences 25(5): 417-440, 2006

Recent advances and future perspectives in cardiac catheterization in children. Revista Espanola de Cardiologia 37 Suppl 1: 26-30, 1984

Recent advances and future perspectives in the management of lung cancer. Current Problems in Surgery 42(8): 540-610, 2005

Corneal tissue engineering: recent advances and future perspectives. Tissue Engineering. Part B, Reviews 21(3): 278-287, 2016

Chloroplast genetic engineering: recent advances and future perspectives. Critical Reviews in Plant Sciences 24(2): 83-107, 2005